Literature DB >> 6175045

Prevention of the platelet alpha-granule release reaction by membrane-active drugs.

C Prowse, D Pepper, J Dawes.   

Abstract

A range of membrane-active drugs were tested for their ability to prevent beta-thromboglobulin and platelet factor 4 release from freshly collected blood platelets. While all the drugs tested could inhibit collagen-induced platelet aggregation, only a few, notably procaine and the anti-malarial drugs chloroquine, hydroxychloroquine, camoquine and quinacrine (mepacrine), effectively prevented the alpha-granule release reaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175045     DOI: 10.1016/0049-3848(82)90241-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

Review 1.  New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.

Authors:  Marc Scherlinger; Vanja Sisirak; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

2.  At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.

Authors:  A Zatta; A Zanetti; E Dejana; M Prosdocimi
Journal:  Agents Actions       Date:  1987-10

3.  Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis.

Authors:  G K Endresen
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

4.  Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.

Authors:  M Prosdocimi; A Zatta; A Gorio; A Zanetti; E Dejana
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

Review 5.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

6.  Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Anthony S Quinn; Pojen P Chen; James J Hathcock; Douglas J Taatjes
Journal:  Blood       Date:  2008-06-24       Impact factor: 22.113

7.  The effects of 2-chloroprocaine on coagulation and fibrinolysis in the parturient: an in vitro study.

Authors:  Bhavani Shankar Kodali; Monica Sa Rego; A Murat Kaynar; Richard D Urman
Journal:  J Anesth       Date:  2014-04-19       Impact factor: 2.078

Review 8.  Platelets in Skin Autoimmune Diseases.

Authors:  Xiaobo Liu; Christian Gorzelanny; Stefan W Schneider
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

Review 9.  The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?

Authors:  Eugenia Quiros Roldan; Giorgio Biasiotto; Paola Magro; Isabella Zanella
Journal:  Pharmacol Res       Date:  2020-05-13       Impact factor: 7.658

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.